Terms: = Brain cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Prognosis
7822 results:
1. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
[TBL] [Abstract] [Full Text] [Related]
2. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
[TBL] [Abstract] [Full Text] [Related]
4. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
5. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
[TBL] [Abstract] [Full Text] [Related]
6. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
7. The relationship between imaging features, therapeutic response, and overall survival in pediatric diffuse intrinsic pontine glioma.
Yu X; Lai M; Li J; Wang L; Ye K; Zhang D; Hu Q; Li S; Hu X; Wang Q; Ma M; Xiao Z; Zhou J; Shi C; Luo L; Cai L
Neurosurg Rev; 2024 May; 47(1):212. PubMed ID: 38727935
[TBL] [Abstract] [Full Text] [Related]
8. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract] [Full Text] [Related]
9. VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis.
Guo M; Zhang J; Han J; Hu Y; Ni H; Yuan J; Sun Y; Liu M; Gao L; Liao W; Ma C; Liu Y; Li S; Li N
J Transl Med; 2024 May; 22(1):419. PubMed ID: 38702818
[TBL] [Abstract] [Full Text] [Related]
10. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
[TBL] [Abstract] [Full Text] [Related]
11. Pituitary abscess: a descriptive analysis of a series of 19 patients-a multi-center experience.
Xue Q; Shi X; Fu X; Yin Y; Zhou H; Liu S; Sun Q; Meng J; Bian L; Tan H; He H
Eur J Med Res; 2024 May; 29(1):262. PubMed ID: 38698484
[TBL] [Abstract] [Full Text] [Related]
12. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
Klabusay M; Bábková B
Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
14. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R; Lu X; Sun X; Wu H
Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
[No Abstract] [Full Text] [Related]
15. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
[TBL] [Abstract] [Full Text] [Related]
16.
Ou Y; Luo H; Zhang Q; Du T; Liu R; Wang D; Chen J; Dong M; Wang Y; Yang Z; Wang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):144. PubMed ID: 38682183
[TBL] [Abstract] [Full Text] [Related]
17. Roles of TRPM channels in glioma.
Chen Z; Xie H; Liu J; Zhao J; Huang R; Xiang Y; Wu H; Tian D; Bian E; Xiong Z
Cancer Biol Ther; 2024 Dec; 25(1):2338955. PubMed ID: 38680092
[TBL] [Abstract] [Full Text] [Related]
18. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
[No Abstract] [Full Text] [Related]
19. HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments.
Bai J; Zhao Y; Shi K; Fan Y; Ha Y; Chen Y; Luo B; Lu Y; Jie W; Shen Z
J Transl Med; 2024 Apr; 22(1):391. PubMed ID: 38678297
[TBL] [Abstract] [Full Text] [Related]
20. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract] [Full Text] [Related]
[Next]